Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $5.1 million.

  • Pharma's Goodwill & Intangibles rose 18347.2% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 18347.2%. This contributed to the annual value of $2.1 million for FY2025, which is 2728.96% up from last year.
  • Per Pharma's latest filing, its Goodwill & Intangibles stood at $5.1 million for Q3 2025, which was up 18347.2% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Pharma's Goodwill & Intangibles ranged from a high of $5.1 million in Q3 2025 and a low of $405000.0 during Q2 2021
  • In the last 5 years, Pharma's Goodwill & Intangibles had a median value of $1.2 million in 2023 and averaged $1.4 million.
  • Per our database at Business Quant, Pharma's Goodwill & Intangibles soared by 1093.75% in 2021 and then surged by 18347.2% in 2025.
  • Pharma's Goodwill & Intangibles (Quarter) stood at $426000.0 in 2021, then soared by 139.91% to $1.0 million in 2022, then increased by 15.66% to $1.2 million in 2023, then soared by 58.12% to $1.9 million in 2024, then surged by 173.46% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $2.0 million for Q2 2025, and $2.1 million during Q1 2025.